Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time ...

New data reveals that percutaneous coronary intervention (PCI) can be safely performed before, during, or after transcatheter aortic valve replacement (TAVR) for patients with stable coronary artery ...

There are limited data from randomized trials to guide a specific follow-up surveillance approach after myocardial revascularization. Whether a follow-up strategy that includes routine functional ...

For people with stable chest pain and an intermediate pretest probability of obstructive coronary artery disease (CAD), an initial CT strategy fared similarly to invasive coronary angiography (ICA) ...

Coronary artery disease — or CAD — is a heart disease that’s often treated with medications as well as lifestyle and dietary changes. If your condition worsens, your doctor might suggest percutaneous ...

A coronary angiography is a test that doctors use to look at the coronary arteries. A coronary angiography may help diagnose certain heart conditions. The coronary arteries bring oxygenated blood to ...

Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were ...

Although P2Y 12 antagonists are effective in patients with non–ST-segment elevation (NSTE) acute coronary syndromes, the effect of the timing of administration — before or after coronary angiography — ...

In patients with acute coronary syndrome (ACS), intravascular ultrasound (IVUS)-guided implantation of a drug-eluting stent improved outcomes compared with angiography guidance alone. "Our study ...